The longevity supplements market is estimated at over $44 billion globally and growing fast. Within that market, quality ranges from interventions with meaningful clinical evidence to compounds sold primarily on theoretical mechanisms and animal data. Navigating this space without wasting money or taking unnecessary risks requires understanding what the evidence actually says.

This guide covers the longevity supplement and peptide categories with the strongest evidence bases, explains the mechanisms, and addresses the honest limitations of what we currently know.

A longevity supplement is any compound taken with the intention of extending health span, delaying age-related disease, or supporting biological processes associated with healthy aging. The category spans everything from widely available vitamins to prescription peptides administered under physician supervision.

The distinction between a supplement and a pharmaceutical matters: supplements are not regulated for efficacy before they reach the market, while prescription compounds require prescriber involvement and, in many cases, have more robust clinical data behind them.

Nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) are precursors that the body converts into NAD+, a coenzyme central to mitochondrial energy production, DNA repair, and cellular aging. NAD+ levels decline reliably with age, and restoring them appears to have meaningful biological effects.

Human clinical trials have confirmed that NR and NMN supplementation raises blood and tissue NAD+ levels. A 2021 study published in Cell Reports showed that NMN supplementation improved physical performance and muscle quality in older men. A 2018 Nature Communications study confirmed that oral NR is safe and bioavailable in humans. These are among the most robustly supported longevity interventions available without a prescription.

Several peptides stand out for their longevity-relevant mechanisms and growing clinical evidence.

Sermorelin is a growth hormone-releasing hormone analogue that stimulates the pituitary to produce growth hormone naturally. It addresses the well-documented age-related decline in growth hormone (somatopause), which contributes to reduced muscle mass, increased fat, slower tissue repair, and reduced energy. Because it works through natural pituitary mechanisms, its safety profile is more favorable than direct growth hormone therapy.

Body protection compound 157 is a synthetic peptide derived from gastric juice with remarkable tissue repair properties in animal models. Research has shown acceleration of healing in tendons, ligaments, muscle, and gastrointestinal tissue. Human data is more limited but consistent with the preclinical findings.

As discussed in detail elsewhere on this site, thymosin alpha-1 modulates immune function, counteracts age-related immune decline, and has clinical approval in 35 countries for infectious disease applications.

Metformin is a decades-old diabetes medication that has attracted serious longevity research attention. It activates AMPK, a cellular energy sensor involved in metabolic regulation and aging pathways. Animal studies have shown life-extension effects. The TAME trial (Targeting Aging with Metformin) is currently studying metformin specifically as a longevity intervention in non-diabetic older adults, making it one of the most seriously investigated pharmaceutical longevity interventions.

Resveratrol attracted enormous interest after early animal studies showed life-extension effects. Human clinical data has been more mixed and has generally failed to replicate the dramatic animal findings. It may have modest benefits for cardiovascular markers, but it is not the longevity breakthrough early research suggested.

Fisetin, quercetin, and other senolytics (compounds designed to clear senescent cells) are biologically interesting, and senolytic therapy is a serious research area. Human clinical trials are ongoing but results in humans remain limited. The theoretical basis is sound; the human evidence base is not yet strong.

Rapamycin, an mTOR inhibitor, has produced consistent life extension in animal models across multiple species. It is being used off-label by some longevity physicians in low-dose intermittent protocols. It is not a supplement but a prescription medication with real side effects and significant immunosuppressive potential that requires close medical supervision.

Before investing in longevity supplements, it is worth acknowledging that the interventions with the largest evidence base for extending healthy lifespan are not pills or injections. Regular vigorous exercise, particularly combining aerobic capacity and strength training, is the most consistently supported longevity intervention across virtually every study design. Caloric restriction and time-restricted eating have strong evidence in multiple model organisms and growing human data. Quality sleep, stress management, and not smoking are not glamorous, but they have outsized effects.

Longevity supplements and peptides are most rationally used as additions to these foundational practices, not substitutes for them.


Individual results may vary. All prescriptions require approval by a licensed medical provider. Compounded medications are not FDA-approved. EllieMD facilitates access to independent healthcare providers and pharmacies and does not provide medical care or dispense medications.